HR 2252 | CAS#13005-07-7

MedKoo Cat#: 534902 | Name: HR 2252

Description:

WARNING: This product is for research use only, not for human or veterinary use.

HR 2252 is a bioactive chemical.

Chemical Structure

HR 2252

CAS#13005-07-7

Theoretical Analysis

MedKoo Cat#: 534902

Name: HR 2252

CAS#: 13005-07-7

Chemical Formula: C28H28N6O2

Exact Mass: 480.2274

Molecular Weight: 480.57

Elemental Analysis: C, 69.98; H, 5.87; N, 17.49; O, 6.66

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

HR 2252; HR-2252; HR2252

IUPAC/Chemical Name

N(1),N(4)-Bis(4-(1-methyl-4,5-dihydro-1H-imidazol-2-yl)phenyl)terephthalamide

InChi Key

LQNZJDKQXRYRHB-UHFFFAOYSA-N

InChi Code

InChI=1S/C28H28N6O2/c1-33-17-15-29-25(33)19-7-11-23(12-8-19)31-27(35)21-3-5-22(6-4-21)28(36)32-24-13-9-20(10-14-24)26-30-16-18-34(26)2/h3-14H,15-18H2,1-2H3,(H,31,35)(H,32,36)

SMILES Code

O=C(NC1=CC=C(C2=NCCN2C)C=C1)C3=CC=C(C(NC4=CC=C(C5=NCCN5C)C=C4)=O)C=C3

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 480.57 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Hamilton BK, Liu Y, Hemmer MT, Majhail N, Ringden O, Kim D, Costa L, Stuart R, Alousi A, Pidala JA, Couriel DR, Aljurf M, Antin JH, Bredeson C, Cahn JY, Cairo M, Choi SW, Dandoy C, Gale RP, Gergis U, Hematti P, Inamoto Y, Kamble RT, MacMillan M, Marks DI, Nemecek E, Nishihori T, Saad A, Savani BN, Schriber J, Seo S, Socié G, Teshima T, Verdonck LF, Waller EK, Wirk M, Spellman SR, Arora M, Chhabra S. Inferior Outcomes with Cyclosporine and Mycophenolate Mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant. 2019 Sep;25(9):1744-1755. doi: 10.1016/j.bbmt.2019.05.019. Epub 2019 May 31. PMID: 31158502; PMCID: PMC7039394. 2: Matsuo K, Machida H, Mariani A, Mandelbaum RS, Glaser GE, Gostout BS, Roman LD, Wright JD. Adequate pelvic lymphadenectomy and survival of women with early- stage epithelial ovarian cancer. J Gynecol Oncol. 2018 Sep;29(5):e69. doi: 10.3802/jgo.2018.29.e69. Epub 2018 May 4. PMID: 30022633; PMCID: PMC6078885. 3: Altwerger G, Florsheim EB, Menderes G, Black J, Schwab C, Gressel GM, Nelson WK, Carusillo N, Passante T, Huang G, Litkouhi B, Azodi M, Silasi DA, Santin A, Schwartz PE, Ratner ES. Impact of carboplatin hypersensitivity and desensitization on patients with recurrent ovarian cancer. J Cancer Res Clin Oncol. 2018 Dec;144(12):2449-2456. doi: 10.1007/s00432-018-2753-y. Epub 2018 Sep 25. PMID: 30255380. 4: Yang H, Pawitan Y, He W, Eriksson L, Holowko N, Hall P, Czene K. Disease trajectories and mortality among women diagnosed with breast cancer. Breast Cancer Res. 2019 Aug 16;21(1):95. doi: 10.1186/s13058-019-1181-5. PMID: 31420051; PMCID: PMC6698019. 5: Perovic D, Kolenc D, Bilic V, Somun N, Drmic D, Elabjer E, Buljat G, Seiwerth S, Sikiric P. Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats. J Orthop Surg Res. 2019 Jul 2;14(1):199. doi: 10.1186/s13018-019-1242-6. PMID: 31266512; PMCID: PMC6604284. 6: Kodali S, Thourani VH, White J, Malaisrie SC, Lim S, Greason KL, Williams M, Guerrero M, Eisenhauer AC, Kapadia S, Kereiakes DJ, Herrmann HC, Babaliaros V, Szeto WY, Hahn RT, Pibarot P, Weissman NJ, Leipsic J, Blanke P, Whisenant BK, Suri RM, Makkar RR, Ayele GM, Svensson LG, Webb JG, Mack MJ, Smith CR, Leon MB. Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis. Eur Heart J. 2016 Jul 21;37(28):2252-62. doi: 10.1093/eurheartj/ehw112. Epub 2016 Mar 31. PMID: 27190101; PMCID: PMC6392433. 7: Ravidà A, Qazi M, Troiano G, Saleh MHA, Greenwell H, Kornman K, Wang HL. Using periodontal staging and grading system as a prognostic factor for future tooth loss: A long-term retrospective study. J Periodontol. 2020 Apr;91(4):454-461. doi: 10.1002/JPER.19-0390. Epub 2019 Sep 25. PMID: 31502244. 8: Gao JJ, Cheng J, Bloomquist E, Sanchez J, Wedam SB, Singh H, Amiri-Kordestani L, Ibrahim A, Sridhara R, Goldberg KB, Theoret MR, Kluetz PG, Blumenthal GM, Pazdur R, Beaver JA, Prowell TM. CDK4/6 inhibitor treatment for patients with hormone receptor-positive, HER2-negative, advanced or metastatic breast cancer: a US Food and Drug Administration pooled analysis. Lancet Oncol. 2020 Feb;21(2):250-260. doi: 10.1016/S1470-2045(19)30804-6. Epub 2019 Dec 16. PMID: 31859246. 9: Matsuo K, Mandelbaum RS, Machida H, Purushotham S, Grubbs BH, Roman LD, Wright JD. Association of tumor differentiation grade and survival of women with squamous cell carcinoma of the uterine cervix. J Gynecol Oncol. 2018 Nov;29(6):e91. doi: 10.3802/jgo.2018.29.e91. PMID: 30207099; PMCID: PMC6189431. 10: Peng D, Zhang CJ, Gong YQ, Hao H, Guan B, Li XS, Zhou LQ. Prognostic significance of HALP (hemoglobin, albumin, lymphocyte and platelet) in patients with bladder cancer after radical cystectomy. Sci Rep. 2018 Jan 15;8(1):794. doi: 10.1038/s41598-018-19146-y. PMID: 29335609; PMCID: PMC5768698. 11: Moon CM, Jung SA, Eun CS, Park JJ, Seo GS, Cha JM, Park SC, Chun J, Lee HJ, Jung Y, Boo SJ, Kim JO, Joo YE, Park DI. The effect of small or diminutive adenomas at baseline colonoscopy on the risk of developing metachronous advanced colorectal neoplasia: KASID multicenter study. Dig Liver Dis. 2018 Aug;50(8):847-852. doi: 10.1016/j.dld.2018.04.001. Epub 2018 Apr 11. PMID: 29730157. 12: Kang X, Shelmerdine SC, Hurtado I, Bevilacqua E, Hutchinson C, Mandalia U, Segers V, Cos Sanchez T, Cannie MM, Carlin A, Sebire NJ, Arthurs OJ, Jani JC. Postmortem examination of human fetuses: comparison of two-dimensional ultrasound with invasive autopsy. Ultrasound Obstet Gynecol. 2019 Feb;53(2):229-238. doi: 10.1002/uog.18828. Epub 2019 Jan 7. PMID: 28782198. 13: Levent S, Kaya Çavuşoğlu B, Sağlık BN, Osmaniye D, Acar Çevik U, Atlı Ö, Özkay Y, Kaplancıklı ZA. Synthesis of Oxadiazole-Thiadiazole Hybrids and Their Anticandidal Activity. Molecules. 2017 Nov 18;22(11):2004. doi: 10.3390/molecules22112004. PMID: 29156575; PMCID: PMC6150172. 14: Peng D, Zhang CJ, Tang Q, Zhang L, Yang KW, Yu XT, Gong Y, Li XS, He ZS, Zhou LQ. Prognostic significance of the combination of preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) in patients with renal cell carcinoma after nephrectomy. BMC Urol. 2018 Mar 15;18(1):20. doi: 10.1186/s12894-018-0333-8. PMID: 29544476; PMCID: PMC5855974. 15: Schaap LA, Quirke T, Wijnhoven HAH, Visser M. Changes in body mass index and mid-upper arm circumference in relation to all-cause mortality in older adults. Clin Nutr. 2018 Dec;37(6 Pt A):2252-2259. doi: 10.1016/j.clnu.2017.11.004. Epub 2017 Nov 15. PMID: 29195733. 16: Kang X, Sanchez TC, Arthurs OJ, Bevilacqua E, Cannie MM, Segers V, Lecomte S, Sebire NJ, Jani JC. Postmortem fetal imaging: prospective blinded comparison of two-dimensional ultrasound with magnetic resonance imaging. Ultrasound Obstet Gynecol. 2019 Dec;54(6):791-799. doi: 10.1002/uog.20217. PMID: 30644623. 17: Clavé MM, Maeda NY, Castro CRP, Bydlowski SP, Lopes AA. Factors influencing outcomes in patients with Eisenmenger syndrome: a nine-year follow-up study. Pulm Circ. 2017 Jul-Sep;7(3):635-642. doi: 10.1177/2045893217721928. Epub 2017 Aug 25. PMID: 28704136; PMCID: PMC5841908. 18: Di Benedetto A, Mottolese M, Sperati F, Ercolani C, Di Lauro L, Pizzuti L, Vici P, Terrenato I, Shaaban AM, Humphries MP, Sundara-Rajan S, Barba M, Speirs V, De Maria R, Maugeri-Saccà M. Association between AXL, Hippo Transducers, and Survival Outcomes in Male Breast Cancer. J Cell Physiol. 2017 Aug;232(8):2246-2252. doi: 10.1002/jcp.25745. Epub 2017 Mar 3. PMID: 27987320. 19: Pearson J, Richardson J, Calnan M, Salisbury C, Foster NE. The acceptability to patients of PhysioDirect telephone assessment and advice services; a qualitative interview study. BMC Health Serv Res. 2016 Mar 28;16:104. doi: 10.1186/s12913-016-1349-y. PMID: 27020840; PMCID: PMC4810506. 20: Miao Y, Yan Q, Li S, Li B, Feng Y. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy. Cancer Biomark. 2016 Jun 7;17(1):33-40. doi: 10.3233/CBM-160614. PMID: 27314290.